Cyclophosphamide for Injection

DRUG2 trials

Sponsors

Chinese PLA General Hospital, BeBetter Med Inc

Conditions

Hepatocellular Carcinoma (HCC)Previously Untreated Peripheral T-Cell Lymphoma

Phase 1

CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma

Not yet recruitingNCT06641453

Chinese PLA General HospitalHepatocellular Carcinoma (HCC)

Start: 2024-11-15End: 2028-11-15Target: 30Updated: 2024-10-16

Phase 2

A Study of BEBT-908 in Combination With Chemotherapy in Patients With Previously Untreated Peripheral T-Cell Lymphoma (PTCL)

Not yet recruitingNCT07676175

BeBetter Med IncPreviously Untreated Peripheral T-Cell Lymphoma

Start: 2026-07-01End: 2028-06-30Target: 120Updated: 2026-06-30